维普中文期刊产品整合服务
260篇 您的检索式:作者名="Takiuchi"
    题名 作者 年代 出处 被引量
1CD13 is a therapeutic target in human liver cancer stem cells显示文摘Haraguchi Naotsugu Ishii Hideshi Mimori Koshi Tanaka Fumiaki Ohkuma Masahisa Kim Ho Min Akita Hirofumi Takiuchi Daisuke Hatano Hisanori Nagano Hiroaki Barnard Graham F Doki Yuichiro Mori Masaki 2010Journal of Clinical Investigation2010,,9:7
2Fluorouracil versus combination of irinotecan plus cisplatin versus S-1 in metastatic gastric cancer: a randomised phase 3 study显示文摘Narikazu Boku Seiichiro Yamamoto Haruhiko Fukuda Kuniaki Shirao Toshihiko Doi Akira Sawaki Wasaburo Koizumi Hiroshi Saito Kensei Yamaguchi Hiroya Takiuchi Junichiro Nasu Atsushi Ohtsu 2009Lancet Oncology2009,,11:5
3Phase Ⅱ study of oxaliplatin plus S-1 as first-line treatment for advanced gastric cancer (G-SOX study)显示文摘Koizumi W Takiuchi H Yamada Y 0,,05:2
4Plasma asymmetric dimethylarginine and coronary and peripheral endothelial dysfunction in hypertensive patients显示文摘Takiuchi S Fuji H Kamide K 2004Am J Hypertens2004,17,9:1
5Quantitative ultrasonic tissue characterization can identify high-risk atherosclerotic alteration in human carotid arteries显示文摘Takiuchi S Rakugi H Honda K 2000Circulation2000,102,7:1
6Evaluation of prognostic factors of esophageal squamous cell carcinoma ( stage Ⅱ - Ⅲ ) after concurrent chemoradiotherapy using biopsy specimens 显示文摘Kii T Takiuchi H Kawabe S 2007Jpn J Clin Oncol2007,37,:1
7Phasell study of oxalipla- tin combined with S - 1 ( SOX ) as first-line therapy for patients with advancedgastric cancer (AGC) 显示文摘Takiuchi H Koizumi W Yamada Y 2009J Clin Oncol2009,27,:1
8Plasmaasymmetric dimethylarginine and coronary and periph-eral endothelial dysfunction in hypertensive patients显示文摘TAKIUCHI S FUJII H KAMIDE K 2009Am J Hypertens2009,17,:1
9Safety of UFT/LV and S-1 as adjuvant therapy for stage III colon cancer in phase III trial:ACTS-CC trial显示文摘Mochizuki I Takiuchi H Ikejiri K 2012Br J Cancer2012,106,7:1
10Retroperitoneal schwannoma 显示文摘Takatera H Takiuchi H Namiki M 1986Urology1986,28,6:1
11Alterationin the coronary blood flow velocity pattern in patients with no reflow and reperfusedacute myocardial infarction显示文摘Iwakura K Ito H Takiuchi S Taniyama Y Nakatsuchi Y Negoro S 1996Circulation1996,94,:1
12Epidermal growth factor receptor is a possible predictor of sensitivity to chemoradiotherapy in the primary lesion of esophageal squamous cell carcinoma显示文摘Gotoh M Takiuchi H Kawabe S 2007Jpn J Clin Oncol2007,37,:1
13Phase II study of oxaliplatin plus S-1 as first-line treatment for advance gastric cancer 显示文摘Koizumi W Takiuchi H Yamada Y 2010Ann Oncol2010,21,5:1
14Safety of UFT/ LV and S-1 as adjuvant therapy for stage III colon can- cer in phase III trial: ACTS-CC trial显示文摘Mochizuki I Takiuchi H Ikejiri K 2012Br J Cancer2012,106,7:1
15Association of insulin - like growth factor - 1 receptor gene polymorphisms with left ventricular mass and geometry in essential hypertension 显示文摘Horio T Kamide K Takiuchi S 2010J Hum ttypertens2010,24,5:1
16Phase Ⅱ study of oxaliplatin plus S-1 as first-line treatment for advanced gastric cancer (G-SOX study) 显示文摘Koizumi W Takiuchi H Yamada Y 2010Ann Oncol2010,21,5:1
17Atherosclerotic alteration in human carotid arteries quantitative ultrasonic tissue characterization can identify high-risk 显示文摘Takiuchi S Rakugi H Honda K 2000Circulation2000,10,2:1
18Phase Ⅱ study of oxaliplatin plus S-I as first-line treatment for advanced gastric cancer ( G-SOX study) 显示文摘Koizumi W Takiuchi H Yamada Y 2010Ann Oncol2010,21,5:1
19Second-line chemotherapy in gastric cancer显示文摘Takiuchi Goto M Kawabe S 2005Gan To Kagaku Ryoho2005,32,1:1
20Fluorouracil versus combination of irinotecan plus cisplatin versus S-1 in metastatic gastric cancer: a randomised phase 3 study显示文摘Narikazu Boku Seiichiro Yamamoto Haruhiko Fukuda Kuniaki Shirao Toshihiko Doi Akira Sawaki Wasaburo Koizumi Hiroshi Saito Kensei Yamaguchi Hiroya Takiuchi Junichiro Nasu Atsushi Ohtsu 2009Lancet Oncology2009,,11:1
返回顶部 每页显示:
共13页 首页 上一页 第1页 下一页 末页 /13 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费